BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 30944972)

  • 1. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
    Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
    Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
    Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus.
    Lin SJ; Chen JY; Kuo ML; Hsiao HS; Lee PT; Huang JL
    Mediators Inflamm; 2016; 2016():9675861. PubMed ID: 27847409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
    Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
    Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon-α mediating the functional damage of CD56
    Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The phenotype of CD3-CD56
    Soelistyoningsih D; Susianti H; Kalim H; Handono K
    Reumatologia; 2022; 60(4):258-265. PubMed ID: 36186836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased oxidative stress contributes to impaired peripheral CD56
    Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
    Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
    Henriques A; Teixeira L; Inês L; Carvalheiro T; Gonçalves A; Martinho A; Pais ML; da Silva JA; Paiva A
    Clin Rheumatol; 2013 Jun; 32(6):805-13. PubMed ID: 23377197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients.
    Lin YL; Lin SC
    Clin Exp Med; 2017 Feb; 17(1):101-109. PubMed ID: 26590595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Arthritis Rheum; 2007 Jan; 56(1):303-10. PubMed ID: 17195234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus.
    Hudspeth K; Wang S; Wang J; Rahman S; Smith MA; Casey KA; ; Manna Z; Sanjuan M; Kolbeck R; Hasni S; Ettinger R; Siegel RM
    Clin Exp Immunol; 2019 May; 196(2):226-236. PubMed ID: 30693467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.
    Schepis D; Gunnarsson I; Eloranta ML; Lampa J; Jacobson SH; Kärre K; Berg L
    Immunology; 2009 Jan; 126(1):140-6. PubMed ID: 18564343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56
    Chen T; Liu C; Li L; Liu H; Wang T; Shao Z; Fu R
    Int J Lab Hematol; 2019 Jun; 41(3):353-363. PubMed ID: 30779419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-γ production by tubulointerstitial human CD56
    Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
    Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity?
    Werner JM; Lang C; Scherer MN; Farkas SA; Geissler EK; Schlitt HJ; Hornung M
    Transpl Immunol; 2011 Jul; 25(1):27-33. PubMed ID: 21635950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus.
    Tang S; Wang Y; Ma X; Xiang X; Zhou X; Li Y; Jia Y; Hu F; Li Y
    Clin Rheumatol; 2023 May; 42(5):1435-1442. PubMed ID: 36629999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Kumari S; Shivam P; Hansa J; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
    Hum Immunol; 2018 Aug; 79(8):616-620. PubMed ID: 29842895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO; Corrente JE; Saad-Magalhães C
    Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired natural killer cell subset phenotypes in human obesity.
    Bähr I; Jahn J; Zipprich A; Pahlow I; Spielmann J; Kielstein H
    Immunol Res; 2018 Apr; 66(2):234-244. PubMed ID: 29560551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.